| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA701: Crisaborole for treating mild to moderate atopic dermatitis in people 2 years and older (terminated appraisal) |
|
Medicine details |
|
| Medicine name | crisaborole (Staquis®) |
| Formulation | ointment |
| Reference number | 2952 |
| Indication | Treatment of mild to moderate atopic dermatitis in adults and paediatric patients from 2 years of age with ≤ 40% body surface area (BSA) affected |
| Company | Pfizer Ltd |
| BNF chapter | Skin |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 13/02/2020 |
| NICE guidance | |